Cargando…
A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin
BACKGROUND: Current use of prescribed or over the counter non-steroidal anti-inflammatory drugs (NSAIDs) for pain and osteoarthritis (OA) have untoward gastrointestinal and cardiovascular related side effects, as a result the need for a safe and effective alternative has become unequivocally crucial...
Autores principales: | Sampalis, John S, Brownell, Lidia Alfaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352039/ https://www.ncbi.nlm.nih.gov/pubmed/22480204 http://dx.doi.org/10.1186/1475-2891-11-21 |
Ejemplares similares
-
UP446, analgesic and anti-inflammatory botanical composition
por: Yimam, Mesfin, et al.
Publicado: (2013) -
Protective Effect of UP446 on Ligature-Induced Periodontitis in Beagle Dogs
por: Yimam, Mesfin, et al.
Publicado: (2019) -
UP1306, a Botanical Composition with Analgesic and Anti-inflammatory Effect
por: Yimam, Mesfin, et al.
Publicado: (2016) -
Clinical and biochemical effects of a combination botanical product (ClearGuard™) for allergy: a pilot randomized double-blind placebo-controlled trial
por: Corren, Jonathan, et al.
Publicado: (2008) -
A Randomized, Double-Blind, Placebo-Controlled Trial of a Polyphenol Botanical Blend on Sleep and Daytime Functioning
por: Tubbs, Andrew S., et al.
Publicado: (2021)